The N-Methyl-D-aspartate receptor antagonist dizocilpine inhibits associative antinociceptive tolerance to morphine in mice: Relation with memory

Journal of Pharmacological Sciences

Volumn 97, Issue 1, 2005, Pages 75-82

  Nakama Kitamura, Mototaka ^a  

^a KWANSEI GAKUIN UNIVERSITY   (Japan)

Author keywords

Associative antinociceptive tolerance; Dizocilpine; Morphine; Pavlovian drug conditioning

Indexed keywords

DIZOCILPINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; ASSOCIATIVE MEMORY; CONDITIONED REFLEX; CONTROLLED STUDY; LATENT PERIOD; MALE; MORPHINE TOLERANCE; NEUROMODULATION; NONHUMAN; RAT;

EID: 14644411080     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.FPJ04024X     Document Type: Article

References (43)

1. Loui AK, Way EL. Overview of opioid tolerance and physical dependence. In: Almeida OFX, Shippenberg TS, editors. Neurobiology of opioids. New York: Springer; 1991. p. 417-439.
2. Cox BM. Molecular and cellular mechanism in opioid tolerance. In: Basbaum AI, Besson J-M, editors. Towards a new pharmacotherapy of pain. New York: Wiley Press; 1991. p. 137-156.
3. Schull JA. A conditioned opponent theory of Pavlovian conditioning and habituation. In: Bower GH, editor. The psychology of learning and motivation. Vol. 13. New York: Academic Press; 1979. p. 57-86.
4. Baker TB, Tiffany ST. Morphine tolerance as habituation. Psychol Rev. 1985;92:78-108.
5. Goudie AJ, Demellweek C. Conditioning factor in drug tolerance. In: Goldberg SR, Stolerman IP, editors. Behavioral analysis of drug dependence. Orlando: Academic Press; 1986. p. 225-285.
6. Adams WJ, Yeh SY, Woods LA, Mitchell CL. Drug-test interaction as a factor in the development of tolerance to the analgesic effect of morphine. J Pharmacol Exp Ther. 1969; 168:251-257.
7. Grisel JE, Watkins LR, Maier SF. Associative and non-associative mechanisms of morphine analgesic tolerance are neurochemically distinct in the rat spinal cord. Psychopharmacology (Berl). 1996;128:248-255.
8. Siegel S. Evidence from rats that morphine tolerance is a learned response. J Comp Physiol Psychol. 1975;89:498-506.
9. Siegel S, Baptista MA, Kim JA, McDonald RV, Weise-Kelly L. Pavloivan psychopharmacology: The associative basis of tolerance. Exp Clin Psychopharmacol. 2000;8:276-293.
10. Tiffany RT, Baker TB. Morphine tolerance in rats: congruence with Pavlovian paradigm. J Comp Physiol. 1981;95:747-762.
11. Kesner RP, Cook DG. Role of habituation and classical conditioning in the development of morphine tolerance. Behav Nerosci. 1983;97:4-12.
12. Paletta MS, Wagner AR. Development of context-specific tolerance to morphine. Support for a dual process interpretation. Behav Neurosci. 1986;100:611-623.
13. Ramsey DS, Woods SC. Biological consequences of drug administration: implications for acute and chronic tolerance. Psychol Rev. 1997;104:170-193.
14. Nakama-Kitamura M, Kawai N, Hayashi T, Imada H. An analysis of the effects of contextual cues on the development of morphine tolerance in rats. Jpn J Neuropsychopharmacol. 2002;22:79-84.
15. Ramos BM, Siegel S, Bueno JL. Occasion setting and drug tolerance. Integr Physiol Behav Sci. 2002;37:165-177.
16. Siegel S, Ramos BMC. Applying laboratory research: drug anticipation and treatment of drug addiction. Exp Clin Psychopharmacol. 2002;10:162-183.
17. Collingridge GL, Singer W. Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol Sci. 1990;11:290-296.
18. Nicoll RA, Malenka RC. Expression mechanisms underlying NMDA receptor-dependent long term potentiation. Ann NY Acad Sci. 1999;30:515-525.
19. Stephens DN. A glutamatergic hypothesis of drug dependence:extrapolation from benzodiazepine receptor ligands. Behav Pharmacol. 1995;6:425-446.
20. Trujillo KA. Effects of noncompetitive N-methyl-D-aspartate receptor antagonists on opiate tolerance and physical dependence. Neuropsychopharmacology. 1995;13:301-307.
21. Belotzertseva IV, Bespalov AY. Effect of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposure or social defeats in mice. Naunyn Schmiedebergs Arch Pharmacol. 1998;358:270-274.
22. Nakama-Kitamura M, Doe N. The role of contextual cues on analgesic tolerance and facilitation of memory with morphine. J Pharmacol Sci. 2003;92:237-244.
23. Tisseo PJ, Inturrisi CE. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate recepter antagonist, LY274614. J Pharmacol Exp Ther. 1993;264:1090-1096.
24. Trujillo KA, Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 1991;251:85-87.
25. Trujillo KA, Akil H. Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonist. Brain Res. 1994;633:178-188.
26. Mele A, Castellano C, Oliverio A. chronic treatment with MK-801 affects the behavioral response to both D1 and D2 dopamine agonist in the one-trial inhibitory avoidance. Psychopharmacology (Berl). 1995;121:401-405.
27. Mele A, Casterino C, Felici A, Caccia A, Oliverio A. Dopamine-NMDA interactions in the modulation of locomotor activity and memory consolidation in mice. Eur J Pharmacol. 1996;308:1-12.
28. Takagi H, Inukai M, Nakama M. A modification of Haffner's method for testing analgesics. Jpn J Pharmacol. 1966;16:287-294.
29. Vazzani A, Serafini R, Stasi MA, Dassia S, Conti I, Tridico RV, et al. Kinetcs of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats. J Exp Ther. 1989; 249:278-283.
30. Bargava HN. Attenuation of tolerance to, and physical dependence on, morphine in the rats by inhibition of nitric oxide synthase. Gene Pharmacol. 1995;26:1049-1053.
31. Belotzertseve IV, Dravolina OA, Neznanova ON, Danysz W, Bespalov AY. Antinociceptive activity of combination of morphine and NMDA receptor antagonists depend on the interinjection interval. Eur J Pharmacol. 2000;396:77-83.
32. Elliot K, Minami N, Kolesnikov YA, Pasternak GW, Inturrisi CE. The NMDA antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, N-nitro-L-arginine, attenuate analgesic tolerance to the mu-opiod morphine but not to kappa opioids. Pain. 1994;56:69-75.
33. Lufty K, Hurlbut DE, Weber E. Blockade of morphine-induced analgesia and tolerance in mice. Brain Res. 1993;616:83-88.
34. McNally GP, Westbrook RF. Effect of systemic, intracerebral, or intrathecal administration of an N-methyl-D-aspartate receptor antagonist on associative morphine analgesic tolerance and hyperalgesia in rats. Behav Neurosci. 1998;112:966-978.
35. Castellano C, Cestari V, Cabib S, Puglisi-Allegra S. The effects of morphine on memory consolidation in mice involve both D1 and D2 dopamine receptors. Behav Neur Biol. 1994;61:156-161.
36. Miles A, Wong RKS. Latent synaptic pathways revealed after tetanic stimulation in the hippocampus. Nature. 1987;308:1-12.
37. Yamada K, Nabeshima T. Brain-derived neurotrophic factor /TrkB signaling signaling in memory process. J Pharmacol Sci. 2003;91:267-270.
38. Kim HS, Jang C, Park W. Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor sensitivity in mice. Pharmacol Biochem Behav. 1996;5:11-17.
39. Gracy NK, Svingos AL, Pickel VM. Dual ultrastructural localization of μ-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens. J Neurosci. 1997;17:4838-4848.
40. Van Bockstaele EJ, Saunders A, Commons KG, Liu XB, Peoples J. Evidence for coexistence of enkephalin and glutamate in axone terminals and cellular sites for functional interactions of the receptors in the rat locus coeruleus. J Comp Neurol. 2000;417:103-114.
41. Olney JW, Labruyere J, Price MT. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science. 1989;244:1360-1362.
42. Nakama-Kitamura M. The role of contextual cues on counter-irritation in the development process of analgesic tolerance with morphine. Life Sci. 2002;9126:1-10.
43. Watanabe T, Nakagawa T, Yamamoto R, Maeda A, Minami M, Satoh M. Involvement of glutamate receptors within the central nucleus of the amygdale in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn J Pharmacol. 2002;88:399-406.